©2022 Stanford Medicine
Cognitive Behavioral Therapy and Chronic Pain Self-Management Within the Context of Opioid Reduction: The EMPOWER Study
Trial ID: NCT03445988
The proposed study will fill several critical gaps in evidence that are preventing patients and physicians from making informed decisions about their pain care. This project will provide patients taking opioids and physicians with the specific evidence they need to choose the most effective route to pain control, reduced pain interference, opioid reduction, and improved role function, thereby improving patient care. The aims of this study are to (1) reduce or contain prescription opioid use while maintaining pain control and (2) compare the effectiveness of the Chronic Pain Self-Management Program (CPSMP), Cognitive Behavioral Therapy for chronic pain (pain-CBT), and no behavioral treatment within the context of patient-centered collaborative opioid tapering (Taper Only). The acronym EMPOWER stands for Effective Management of Pain and Opioid-Free Ways to Enhance Relief. To learn more about the EMPOWER study, please visit: empower.stanford.edu.
Comparative Effectiveness of Pain Cognitive Behavioral Therapy and Chronic Pain Self-Management Within the Context of Opioid Reduction: The EMPOWER Study
- Chronic non-cancer pain (≥ 6 months in duration)
- Currently receiving prescription opioids (≥ 10 MEDD) for ≥ 3 months
- Unable to provide informed consent
- Unable to participate in group treatments in a meaningful way (e.g., evident cognitive
impairment or lack of English fluency)
- Moderate to severe opioid use disorder
To learn more about our recruitment, please visit: empower.stanford.edu.
behavioral: Cognitive Behavioral Therapy
behavioral: Chronic Pain Self Management Program
other: Usual Care
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Beth Darnall, Ph.D.